TFAP4/Wnt/beta-catenin-IN-1 (Compound A61) is an orally active TFAP4/Wnt/beta-catenin inhibitor. TFAP4/Wnt/beta-catenin-IN-1 has significant anticancer activity against a variety of cancer cells (such as gastric cancer, lung cancer, breast cancer, etc.), and has the strongest anticancer activity against MGC-803 gastric cancer cells (IC50: 3.92 µM). TFAP4/Wnt/beta-catenin-IN-1 induces apoptosis and cell cycle arrest (S phase) in cancer cells by inhibiting the TFAP4/Wnt/beta-catenin signaling pathway. TFAP4/Wnt/beta-catenin-IN-1 can be used in the study of gastric cancer[1].
Molekulargewicht:
513.47
Formel:
C27H33BrN2O3
Target-Kategorie:
Wnt,beta-catenin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten